2353
Gilead (NASDAQ:GILD) Says No To Dividend Payments
Gilead Sciences, Inc. (NASDAQ:GILD) has become every investor’s dream come true. The company has gone on to display remarkable figures…
Browsing: BioPharma
1930
Insys Therapeutics (NASDAQ:INSY) Figures Increase
Shares of Insys Therapeutics (NASDAQ:INSY) are doing well. The third quarter results were very impressive; showing increasing sales growth for…
1324
Cancer Drugmaker Dendreon (NASDAQ:DNDN) Files Chapter 11 Bankruptcy
Dendreon Corporation (NASDAQ:DNDN), manufacturer of drugs for prostate cancer, has filed Chapter 11 bankruptcy protection leading to either takeover by…
590
Sarepta Therapeutics (NASDAQ: SRP) Stocks Implode
Shares of Sarepta Therapeutics (NASDAQ:SRP), a clinical-stage engineer of RNA-based therapeutics that is principally centered around making medications intended to…
2138
AbbVie (NYSE: ABBV) Latest Drug Could Push Gilead Sciences (NASDAQ:GILD) Off the Top
Drugs going off-patent has damaged the pharmaceutical world intensely. Pharma companies thrive upon their drug business, the originality of their…
725
Here is How Celgene Corporation (NASDAQ:CELG) Raised its Stocks
As soon as Celgene (NASDAQ:CELG) – the prominent biopharmaceutical company – reported earnings results that were unexpectedly well, and updates…